ARTICLE I. DEFINITIONSSecurities Purchase Agreement • November 12th, 2004 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 12th, 2004 Company Industry Jurisdiction
EXHIBIT 4.3 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of November 10, 2004, among Generex Biotechnology Corporation, a Delaware corporation (the "Company"), and the purchasers...Registration Rights Agreement • November 12th, 2004 • Generex Biotechnology Corp • Pharmaceutical preparations
Contract Type FiledNovember 12th, 2004 Company Industry
EXHIBIT 4.2 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Securities Agreement • November 12th, 2004 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 12th, 2004 Company Industry Jurisdiction
EXHIBIT 4.6 CUSTODIAL AND SECURITY AGREEMENT -------------------------------- THIS CUSTODIAL AND SECURITY AGREEMENT (this "Agreement") is made as of November 10, 2004, by and among Generex Biotechnology Corporation, a Delaware corporation with an...Custodial and Security Agreement • November 12th, 2004 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 12th, 2004 Company Industry Jurisdiction
EXHIBIT 4.7 TO: The Purchasers of Generex Biotechnology Corporation 6% Convertible Debentures, Warrants and Additional Investment Rights Gentlemen: This letter will confirm my agreement to vote all shares of Generex Biotechnology Corporation, a...Voting Agreement • November 12th, 2004 • Generex Biotechnology Corp • Pharmaceutical preparations
Contract Type FiledNovember 12th, 2004 Company IndustryThis letter will confirm my agreement to vote all shares of Generex Biotechnology Corporation, a Delaware corporation (the "Company") voting stock over which I have voting control in favor of any resolution presented to the shareholders of the Company to approve the issuance, in the aggregate, more than 19.999% of the number of shares of common stock of the Company outstanding on the date of closing of the pursuant to that certain Securities Purchase Agreement, dated November 10, 2004, among the Company and the purchasers signatory thereto (the "Purchase Agreement") and the other agreements entered into in connection therewith or as otherwise may be required by the applicable rules and regulations of the American Stock Exchange (or any successor entity). This agreement is given in consideration of, and as a condition to enter into such Securities Purchase Agreement and is not revocable by me.